Desmopressin Response in the Young

NCT00230594 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Nocturnal Enuresis

Interventions

DRUG: desmopressin
DRUG: placebo

Sponsor

Ferring Pharmaceuticals